$PRTA News

UPDATED: Watching Prothena; Shares Spike Higher, Form4 Filing Shows William P. Scully Bought 100,000 Shares At An Average Price Of $9.81/Share

Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $20

Prothena (NASDAQ:PRTA) Smashes Q1 Estimates on $50 Million Milestone Payment, Shares Steady

Prothena Corp Q1 EPS $0.60 Beats $(0.34) Estimate, Sales $51.084M Beat $1.010M Estimate

Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy

Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade

Prothena Announces up to $100 Million Share Repurchase Plan

Prothena shares are trading higher after the company announced a $100 million share buyback.

Prothena shares are trading higher after the company announced a $100 million share buyback.

Prothena Announces $100M Share Buyback

Prothena Corporation plc Q4 2025 Earnings Call Summary

RBC Capital Maintains Sector Perform on Prothena Corp, Raises Price Target to $12

Prothena Corporation plc 2025 Q4 - Results - Earnings Call Presentation

Prothena Corp PLC (PRTA) Q4 2025 Earnings Call Highlights: Strategic Advancements and Financial ...

Prothena Q4 Earnings Call Highlights

Prothena Corporation (NASDAQ:PRTA) Reports Q4 2025 Revenue Miss, Highlights Pipeline Progress and 2026 Cash Guidance

Prothena: Q4 Earnings Snapshot

Prothena Corporation plc (PRTA) Q4 2025 Earnings Call Transcript

Prothena Corp Q4 Earnings Assessment

Prothena Corp Q4 EPS $(0.40) Beats $(0.54) Estimate, Sales $21.000K Miss $1.334M Estimate